EVALUATION OF CARDIOVASCULAR DISEASE AND FATTY LIVER DISEASE IN TYPE 2 DIABETES SUBJECTS ON ULTRASONOGRAPHY. International Research Journal of Pharmacy, [S. l.], v. 15, n. 6, p. 35–39, 2024. Disponível em: https://irjponline.org/index.php/irjp/article/view/92. Acesso em: 1 jun. 2026.